DBV Technologies S.A. (DBVT) stock
DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 6/30
$9.02−0.40 (-4.25%)
Close on Nov 20, 2026Market cap $567.16MP/E –Yield –
DBV Technologies free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
DBV Technologies's free cash flow for the twelve months ending Sep 30, 2026 was -$191.71M. For fiscal 2025 it was -$121.71M. The highest annual figure on record is -$56.42M in fiscal 2022.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$121.71M | – |
| FY2024 | Dec 31, 2024 | -$106.81M | – |
| FY2023 | Dec 31, 2023 | -$80.33M | – |
| FY2022 | Dec 31, 2022 | -$56.42M | – |
| FY2021 | Dec 31, 2021 | -$109.15M | – |
| FY2020 | Dec 31, 2020 | -$168.40M | – |
| FY2019 | Dec 31, 2019 | -$153.91M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$53.70M | – |
| Q2 FY2026 | Jun 30, 2026 | -$53.00M | – |
| Q1 FY2026 | Mar 31, 2026 | -$49.50M | – |
| Q4 FY2025 | Dec 31, 2025 | -$35.51M | – |
| Q3 FY2025 | Sep 30, 2025 | -$32.60M | – |
| Q2 FY2025 | Jun 30, 2025 | -$33.90M | – |
| Q1 FY2025 | Mar 31, 2025 | -$19.70M | – |
| Q4 FY2024 | Dec 31, 2024 | -$12.13M | – |
| Q3 FY2024 | Sep 30, 2024 | -$22.85M | – |
| Q2 FY2024 | Jun 30, 2024 | -$35.81M | – |
| Q1 FY2024 | Mar 31, 2024 | -$36.03M | – |
| Q4 FY2023 | Dec 31, 2023 | -$14.04M | – |
| Q3 FY2023 | Sep 30, 2023 | -$19.62M | – |
| Q2 FY2023 | Jun 30, 2023 | -$25.72M | – |
| Q1 FY2023 | Mar 31, 2023 | -$20.95M | – |
| Q4 FY2022 | Dec 31, 2022 | -$23.90M | – |
| Q3 FY2022 | Sep 30, 2022 | -$20.42M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.49M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.61M | – |
| Q4 FY2021 | Dec 31, 2021 | -$19.70M | – |
| Q3 FY2021 | Sep 30, 2021 | -$22.94M | – |
| Q2 FY2021 | Jun 30, 2021 | -$30.13M | – |
| Q1 FY2021 | Mar 31, 2021 | -$36.39M | – |
| Q2 FY2020 | Jun 30, 2020 | -$40.78M | – |
| Q1 FY2020 | Mar 31, 2020 | -$50.50M | – |
See a number that looks wrong?